News
But three of those FDA employees told CNN that Elsa just makes up nonexistent studies, something commonly referred to in AI ...
The FDA's 'Elsa' AI, intended to speed up drug approvals, is reportedly fabricating studies, part of a wider trend of ...
2d
Futurism on MSNThe FDA Is Using an AI to "Speed Up" Drug Approvals and Insiders Say It's Making Horrible MistakesInsiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug ...
Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is ...
The Food and Drug Administration's new AI tool, Elsa, is reportedly generating false studies, raising concerns about the ...
Stoned AI delivers hallucinations and headaches The Trump administration is flogging artificial intelligence as the silver ...
With reports that FDA’s AI Elsa is “confidently hallucinating” studies that don’t exist, the use of AI to streamline drug ...
2d
Que.com on MSNAI in FDA Drug Approvals Sparks Controversy Over Fabricated StudiesIn recent years, Artificial Intelligence (AI) has made significant strides across various sectors, providing innovative solutions and enhancing efficiency. However, ...
The FDA's generative AI, Elsa, has a massive hallucination problem, according to the agency's employees themselves.
The Trump administration is supportive of AI adoption in healthcare, but FDA insiders told CNN that the agency’s new AI chatbot is deeply flawed.
GoodRx reports that in 2025, novel drug and biosimilar approvals lag slightly behind last year, while first generic approvals ...
The Food and Drug Administration (FDA) is looking to AI to solve the problem of lengthy approval processes, as the Trump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results